Remetinostat
Remetinostat (SHP-141) is a hydroxamate-based histone deacetylase (HDAC) inhibitor under investigation for cutaneous T-cell lymphoma. Research applications include in vitro studies on lymphoma cell lines and in vivo preclinical models to assess its therapeutic potential and mechanisms of action.
Product Specifications
CAS Number
946150-57-8
Product Name Alternative
Inhibit, Inhibitor, Histone deacetylases, HDAC, Remetinostat, SHP141, SHP-141, SHP 141
Field of Research
Epigenetics & Chromatin, Molecular Biology
Purity
95.07% (May vary between batches)
Solubility
DMSO:150 mg/mL (463.91 mM)
Smiles
O (C (CCCCCCC (NO) =O) =O) C1=CC=C (C (OC) =O) C=C1
Molecular Formula
C16H21NO6
Molecular Weight
323.34
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
